Document and Entity Information - USD ($)

12 Months Ended

Dec. 31, 2022

Feb. 25, 2023

Jun. 30, 2022

Document Document And Entity Information [Abstract]

Entity Registrant Name

ATEA PHARMACEUTICALS, INC.

Trading Symbol

AVIR

Entity Central Index Key

0001593899

Current Fiscal Year End Date

--12-31

Entity Filer Category

Accelerated Filer

Entity Common Stock, Shares Outstanding

83,341,574

Document Fiscal Year Focus

2022

Document Fiscal Period Focus

FY

Document Type

10-K

Amendment Flag

false

Document Period End Date

Dec. 31, 2022

Entity Small Business

false

Entity Shell Company

false

Entity Emerging Growth Company

false

Entity Current Reporting Status

Yes

Entity Tax Identification Number

46-0574869

Entity File Number

001-39661

Entity Address, Address Line One

225 Franklin Street

Entity Address, Address Line Two

Suite 2100

Entity Address, City or Town

Boston

Entity Address, State or Province

MA

Entity Address, Postal Zip Code

02110

City Area Code

857

Local Phone Number

284-8891

Entity Interactive Data Current

Yes

Title of 12(b) Security

Common Stock, $0.001 par value per share

Security Exchange Name

NASDAQ

Entity Incorporation, State or Country Code

DE

Document Annual Report

true

Document Transition Report

false

Entity Well-known Seasoned Issuer

No

Entity Public Float

$ 537,283,731

Entity Voluntary Filers

No

ICFR Auditor Attestation Flag

true

Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive proxy statement for its 2023 Annual Meeting of Stockholders, which the registrant intends to file with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended December 31, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K.

Auditor Firm ID

185

Auditor Name

KPMG LLP

Auditor Location

Boston, Massachusetts